medigraphic.com

2009, Number 4

<< Back Next >>

Cir Cir 2009; 77 (4)

Valor de la gammagrafía con Tc-99m-tetrofosmín en el diagnóstico del cáncer bien diferenciado de tiroides

Gallegos-Hernández JF, Pichardo-Romero P, Esparza-Pérez H, Reséndiz-Colosia JA, Minauro-Muñoz GG, Hernández-Hernández DM

Language: Spanish
References: 13
Page: 275-278
PDF size: 72.86 Kb.


ABSTRACT

Background: Patients with cold thyroid nodules without ultrasound malignant suspicion and with benign/undetermined cytology may be subjected to follow-up surveillance. 99mTCtetrofosmin scan (99mTC-TS) may identify patients where this observation can be performed with more certainty. Absence of uptake never occurs in carcinoma patients. Our objective was to determine the 99mTC-TS negative predictive value (NPV) in patients with cold thyroid nodules. Methods: An evaluation with 99mTC-TS was conducted prior to surgery in patients with thyroid gland tumor who were candidates for surgery. All patients underwent thyroidectomy according to histology; NPV and test sensitivity were evaluated when compared with the histopathological result. Then, 296-370 MBq (8-10 mCi) of 99mTC-tetrofosmin was administered; scan images were evaluated after 120 min. Scan result was reported as a) with increased metabolic activity (IMA) or b) without increased metabolic activity (WIMA). Results: Included in the study were 86 consecutive patients. In 60 patients, the scan showed IMA, 20/60 (33%) with carcinoma, 67% with benign nodule. In 26 (30.2%) the scan was WIMA, in this group 3/26 (11.5%) had carcinoma and (88.4%) had a benign neoplasia. Sensitivity = 91.43 (95% CI = 80.73-100), specificity = 45.10 (95% CI = 30.46-59.73), positive predictive value = 53.33 (95% CI = 39.8-66.79) and NPV = 88.46 (95% CI 74.26-100). Negative probability ratio = 0.19. Conclusions: IMA-99mTC-TS is less specific in thyroid cancer; nevertheless, in WIMA patients the possibility of carcinoma is 13%. Most patients (70%) showed IMA, 33% with carcinoma. WIMA-NPV = 30%. 99mTC-TS may be useful in therapeutic decision of patients with thyroid nodule with concerns about surgery. Its usefulness lies in the NPV.


REFERENCES

  1. 1.Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Ann Intern Med 1968;69:537-540.

  2. 2.Tan GH, Garib H. Thyroid incidentalomas; management approaches to non-palpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997;126:226-281.

  3. The American Thyroid Association Guidelines Taskforce (ATA).Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:1-34.

  4. Marqusee E, Benson CB, Frates MC, Doubilet PM, Larsen PR, Cibas ES,et al. Usefulnes of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 2000;1339:696-700.

  5. NCCN. Clinical Practices Guidelines in Oncology. Thyroid Cancer. V. 2008.MS-1-MS-30.

  6. Ezzat S, Sarti DA, Cain DR, Braunstein GD. Thyroid incidentalomas:prevalence by ultrasonography and palpation. Arch Intern Med 1994;154:1838- 1840.

  7. Mazzaferri EL. Thyroid carcinoma: papillary and follicular. In: Mazzaferri EL, Samaan N, eds. Endocrine Tumors. Cambridge: Blackwell Scientific Publications; 1993. pp. 278-333.

  8. 8.Yeh MW, Demircan O, Ituarte P, Clark OH. False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid 2004;14:207-215.

  9. 9.Boi F, Lai ML, Deias C, Piga M, Serra A, Uccheddu A, et al. The usefulness of 99mTc-sestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. Eur J Endocrinol 2003;149:493-498.

  10. Gallegos HJF, Pichardo RPA, Hernández SJM, Correa L, Iwasake L, Flores DR, et al. Usefulness of Tc99-tetrofosmin in papillary thyroid cancer. New York: Proceedings American Thyroid Association Meeting (ATA); 2007.

  11. Kelly DC, Forster, AM, Higley B, Archer CM, Booker FS, Canning LR, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222-227.

  12. Hurtado-López M, Martínez-Dunker C. Negative MIBI thyroid scans exclude differentiated and medullar thyroid cancer in 100% of patients with hypofunctioning thyroid nodules. Eur J Nucl Med Mol Imaging 2007;34:1701-1703.

  13. Alonso O, Lago G, Mut F, Hermida JC, Nuñez M, De Palma G, et al.Thyroid imaging with Tc-99mMIBI in patients with solitary cold single nodules on pertechnetate imaging. Clin Nucl Med 1996;21:363-367.




2020     |     www.medigraphic.com